ClinicalTrials.gg
RecruitingNCT06967896Updated May 27, 2026

Different Models of Tracheal Catheters Are Used for Female Thyroid Glands

An observational study in Sore Throat, Tracheal Tubes With an Inner Diameter of 6.0mm and Tracheal Tubes With an Inner Diameter of 6.5mm, sponsored by Anqing Municipal Hospital. Recruiting at 1 site in China. Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-05-27.

Primary conditionPharyngitis(the registry's first term)UnverifiedIs this wrong?The registry often attaches Pharyngitis to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Anqing Municipal Hospital · Observational

From the registry’s dates

  • Started May 2025; still recruiting 1 year 5 months later.
Study type
Observational
Model
Case-control
Time perspective
Other
Enrollment
180
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

Objective:Compare whether the use of tracheal catheters of models 6.0 and 6.5 causes less sore throat in women after thyroid surgery compared with the traditional use of model 7.0 tracheal catheters.Methods: Investigators enrolled 180 female patients with American Society of Anesthesiologists (ASA) physical status I and III, aged 18-65 years, and scheduled for elective undergoing thyroid surgery with general anesthesia. The participants were randomly assigned into three groups(n=60 each group):Group A: Tracheal catheter group with an inner diameter of 6.0mm, Group B: Tracheal catheter group with an inner diameter of 6.5mm, Group C: Tracheal catheter group with an inner diameter of 7.0mm.The incidence and severity of postoperative sore throat were recorded in three groups at 1 h, 6 h, 24 h and 48 h after operation.

02

Conditions studied

  • Sore Throat
  • Tracheal Tubes With an Inner Diameter of 6.0mm
  • Tracheal Tubes With an Inner Diameter of 6.5mm
  • Tracheal Tubes With an Inner Diameter of 7.0mm

Browse trials for

Keywords

  • thyroid surgery
  • sore throat
  • Tracheal tube
03

In context

Pharyngitis Unverified

226 studies on the registry are indexed under Pharyngitis; 35 are open to participants now.

This study's planned enrollment of 180 is below the median of 289 across 33 observational studies indexed under Pharyngitis.

Browse Pharyngitis studies →

Lead sponsor

Anqing Municipal Hospital is the lead sponsor of 11 studies on the registry; 6 are open to participants now.

Compared within Pharyngitis, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Healthy female thyroid surgery patients, ages 18-65 years, did not have serious systemic disease

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female;
  • Thyroid surgery should be performed under general anesthesia (GA) at an appropriate time;
  • I-III;
  • Aged 18-65 years;
  • less than 35Kg/m2
  • In line with ethics, patients voluntarily accept this experiment and sign .

Exclusion criteria

Exclusion Criteria:

  • Reflux esophagitis, preoperative sore throat, chronic pharyngitis, preoperative hoarseness, use of anticoagulants or , high risk of reflux or aspiration, dysphagia, previous oral or pharyngeal surgical intervention, bleeding disorder, severe heart, lung, liver and kidney dysfunction
  • Upper respiratory tract infection occurred within 2 weeks before surgery
  • Unable to insert ET (no more than two intubations)
  • Patients with hoarseness or sore throat before surgery
  • Language communication, hearing impairment or brain dysfunction such as stroke, unable to communicate
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Observational model
Case-control
Time perspective
Other
Enrollment
180 participants (estimated)
Patient registry
No

Groups and cohorts

  • 6.0#

    Insert the tracheal tube of model 6.0#

  • 6.5#

    Insert the tracheal tube of model 6.5#

  • 7.0#

    Insert the tracheal tube of model 7.0#

06

What researchers measure

Primary outcomes

  1. The incidence of postoperative sore throat

    The incidence of postoperative sore throat

    Time frame: at 1 hour, 6 hour, 24 hour and 48 hour after operation

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06967896
Lead sponsor
Anqing Municipal Hospital
Responsible party
Sponsor
First posted
May 13, 2025
Start date
May 25, 2025
Primary completion
Oct 1, 2026 (estimated)
Completion
Oct 1, 2026 (estimated)
Last update
May 27, 2026

Study contacts

Sun Ling Lu Sun Ling LU, Master's degree
Contact
348092640@qq.com
15955565806
Xu Si Qi Xu Si Qi, Doctor
Contact
errtg555@163.com
13865192106

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion